| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,6899 | -1,13% | €721,46M | €607,60K | |
| €41,0407 | +2,75% | €721,03M | €53,96K | |
| €17,5929 | +3,62% | €719,98M | €219,91K | |
EVC Entravision Communication | €7,7583 | +4,84% | €719,13M | €963,27K | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €24,5449 | +3,31% | €717,74M | €193,58K | |
| €23,1724 | +4,17% | €716,12M | €52,99K | |
AMPH Amphastar Pharmaceuticals, Inc. | €16,2032 | +3,92% | €715,20M | €194,73K | |
MATW Matthews International Corp | €21,6777 | -0,98% | €712,59M | €92,83K | |
TBPH Theravance Biopharma, Inc. | €14,1045 | +2,96% | €712,44M | €162,41K | |
MPB Mid Penn Bancorp, Inc. | €27,8019 | +2,54% | €712,07M | €38,93K | |
KRO Kronos Worldwide, Inc. | €5,9073 | -2,90% | €711,83M | €106,72K | |
ADAM Adamas Trust, Inc. Common Stock | €7,7660 | +2,67% | €711,39M | €214,60K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €18,8665 | +0,16% | €709,82M | €24,89K | |
ROOT Root, Inc. Class A Common Stock | €45,2064 | +0,32% | €708,98M | €70,41K | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,1541 | +0,73% | €708,46M | €32,16K | |
